1'-(TERT-BUTOXYCARBONYL)SPIRO[CYCLOPENTANE-1,3'-INDOLINE]-5'-CARBOXYLIC ACID

Catalog No. :
ACJYEJ170
CAS No. :
2177259-38-8
Molecular Formula :
C18H23NO4
Molecular Weight :
317.39

IUPAC Name:1'-(tert-butoxycarbonyl)spiro[cyclopentane-1,3'-indoline]-5'-carboxylic acid

1'-(TERT-BUTOXYCARBONYL)SPIRO[CYCLOPENTANE-1,3'-INDOLINE]-5'-CARBOXYLIC ACID structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$471.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1'-(TERT-BUTOXYCARBONYL)SPIRO[CYCLOPENTANE-1,3'-INDOLINE]-5'-CARBOXYLIC ACID
IUPAC Name1'-(tert-butoxycarbonyl)spiro[cyclopentane-1,3'-indoline]-5'-carboxylic acid
MDL No.MFCD28390461
Molecular FormulaC18H23NO4
Molecular Weight317.39
SMILESO=C(C1=CC(C23CCCC2)=C(N(C(OC(C)(C)C)=O)C3)C=C1)O
InChI KeyHDEDXVDMANDDLS-UHFFFAOYSA-N
Synonym1-[(2-Methylpropan-2-yl)oxycarbonyl]spiro[2H-indole-3,1'-cyclopentane]-5-carboxylic acid;Spiro[cyclopentane-1,3'-[3H]indole]-1',5'(2'H)-dicarboxylic acid, 1'-(1,1-dimethylethyl) ester;1'-(Tert-butoxycarbonyl)spiro[cyclopentane-1,3'-indoline]-5'-carboxylic acid
CAS No.2177259-38-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJYEJ170 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNHDZ047 route compound structure diagram
    ACNHDZ0472177266-03-2 In Stock
  2. Then
  3. ACJYEJ170 route product structure diagram
    ACJYEJ1702177259-38-8
Inquiry

2. ACJYEJ170 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJYEJ170 route product structure diagram
    ACJYEJ1702177259-38-8
Inquiry

Comments (0)